Rathbones Group’s Elevance Health ELV Stock Holding History

Rathbones Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,250	Closed	-$207K	–	321
2017 Q1	$207K	Sell	1,250 -560	-31%	-$89.1K	0.01%	285
2016 Q4	$260K	Hold	1,810	–	–	0.01%	252
2016 Q3	$227K	Hold	1,810	–	–	0.01%	276
2016 Q2	$238K	Hold	1,810	–	–	0.01%	256
2016 Q1	$252K	Hold	1,810	–	–	0.02%	242
2015 Q4	$250K	Hold	1,810	–	–	0.02%	249
2015 Q3	$253K	Hold	1,810	–	–	0.02%	249
2015 Q2	$297K	Hold	1,810	–	–	0.02%	250
2015 Q1	$279K	Hold	1,810	–	–	0.02%	256
2014 Q4	$227K	Hold	1,810	–	–	0.01%	280
2014 Q3	$217K	Buy	+1,810	New	+$208K	0.02%	271

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rathbones Group's ELV Position: Q2 2017 in Review

Rathbones Group sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 1,250 shares — an estimated $207K sold.

Rathbones Group first reported a position in ELV in Q3 2014 and held it in 11 quarters. The position peaked at $297K in Q2 2015. 852 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

Rathbones Group reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
Rathbones Group sold 1,250 Elevance Health shares in Q2 2017, an estimated $207K.
Rathbones Group first reported a position in Elevance Health in Q3 2014 and held it in 11 quarters.
Rathbones Group's Elevance Health position peaked at $297K in Q2 2015.
852 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Rathbones Group's 13F filing for Q2 2017, filed 10 Aug 2017.